D59.8
Other acquired hemolytic anemias
Clinical Classification Guidelines
Medical Intelligence & Overview
Other acquired hemolytic anemias are a group of conditions characterized by the premature destruction of red blood cells in the body. This disrupts the normal balance between red blood cell production and destruction, leading to a shortage of healthy red blood cells, a condition known as anemia. These disorders can develop suddenly or gradually and may be caused by various factors, including immune reactions, certain medications, or underlying diseases. Recognizing the signs and understanding the causes of these conditions can help in managing them effectively, although specific treatments should always be guided by a healthcare professional.
Causes & Symptoms
Clinical Causes: Autoimmune responses where the body's immune system mistakenly attacks its own red blood cells. Reaction to certain medications, such as penicillin or cephalosporins, which can trigger immune-mediated hemolysis. Underlying diseases like systemic lupus erythematosus or lymphomas that may cause immune reactions against red blood cells. Infections that can prompt immune responses leading to red blood cell destruction. Exposure to toxic substances or chemicals that damage red blood cell membranes. Genetic mutations acquired later in life affecting red blood cell integrity or immune regulation.
Key Symptoms: Fatigue and weakness from reduced oxygen-carrying capacity of the blood. Paleness of the skin and mucous membranes. Shortness of breath, especially during exertion. Rapid heartbeat or palpitations. Dark-colored urine due to the presence of hemoglobin breakdown products. Jaundice (yellowing of the skin and eyes) caused by rapid breakdown of red blood cells. Enlarged spleen or liver in some cases. Back pain or chest pain in severe instances.
Diagnostic & Treatment
Diagnosis Path: Diagnosing other acquired hemolytic anemias involves several tests:
Treatment Protocols: Management of other acquired hemolytic anemias depends on the underlying cause and severity:
Clinical Advice & FAQs
Billing Guidance
Is D59.8 a billable ICD-10 code?
Yes, D59.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D59.8?
Clinical documentation must specify the nature of Other acquired hemolytic anemias and any associated comorbidities for accurate reporting.
Cite this Clinical Reference